EP2 Agonist from Non-Prostanoid Structures Designed as PGE2 Antagonists

摘要

A method of treating ocular hypertension, lowering intraocular pressure, pain or inflammation, comprising administering to a mammal a pharmaceutical composition of an EP₂-receptor agonist represented by;